| All Releases |
TranS1 Appoints Paul A. LaViolette to Board of Directors
Aug 11, 2008 |
|
TranS1 Inc. Reports Operating Results for the Second Quarter of 2008
Jul 31, 2008 |
|
TranS1 Inc. Schedules Second Quarter 2008 Earnings Release and Conference Call for Thursday, July 31, 2008
Jul 28, 2008 |
|
TranS1 Inc. Schedules Second Quarter 2008 Earnings Release and Conference Call for Thursday, July 31, 2008
Jul 25, 2008 |
|
TranS1 Inc. Pre-Announces Q2 2008 Revenues
Jul 2, 2008 |
|
TranS1 Inc. Announces the First Patients Treated With Its Percutaneous Nucleus Replacement, PNR, in Europe
Jun 25, 2008 |
|
TranS1 Inc. to Present At the Bank of America 2008 Health Care Conference
May 8, 2008 |
|
TranS1 Inc. Reports Operating Results for the First Quarter of 2008
May 1, 2008 |
|
TranS1 Inc. Receives FDA 510(k) Clearance for the AxiaLIF 2L, Two Level Percutaneous Lumbar Fusion System
Apr 28, 2008 |
|
TranS1 Inc. Schedules First Quarter 2008 Earnings Release and Conference Call for Thursday, May 1, 2008
Apr 15, 2008 |
|
TranS1 Inc. to Present At the 28th Annual Cowen and Company Health Care Conference and 11th Annual Lehman Brothers Healthcare Conference
Mar 13, 2008 |
|
TranS1 Inc. Reports Operating Results for the Fourth Quarter and Full Year 2007
Feb 21, 2008 |
|
TranS1 Inc. Schedules Conference Call to Discuss Physician Re-imbursement for Tuesday, February 19, 2008
Feb 18, 2008 |
|
TranS1 Inc. Schedules Fourth Quarter and Full Year 2007 Earnings Release and Conference Call for Thursday, February 21, 2008
Feb 15, 2008 |
|
TranS1 Appoints Joseph P. Slattery to Board of Directors
Dec 3, 2007 |
|
TranS1 Inc. Reports Operating Results for the Third Quarter of 2007
Nov 8, 2007 |
|
TranS1 Inc. Schedules Third Quarter 2007 Earnings Release and Conference Call for Thursday November 8th, 2007
Nov 2, 2007 |
|
Trans1 Inc. Announces Initial Public Offering of 5,500,000 Shares
Oct 17, 2007 |
|
TranS1® Announces Major Clinical Milestone
Jan 30, 2007 |
|
TranS1’s AxiaLIF® Honored as Most Promising Product in 2006
Nov 16, 2006 |
|
|
|
